RENALYTIX PLC LS-0025

Research RENALYTIX PLC LS-0025 (2O9) on Bullrun: market cap EUR 8.74M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker2O9
• ExchangeF
• CountryUnited Kingdom
• SectorHealthcare
• IndustryHealth Information Services
• CurrencyEUR
• Market capEUR 8.74M
• Financial periodQ4 2024
• RevenueEUR 729.00K
• Net income-EUR 3.88M
• Free cash flow-EUR 6.50M
• Gross margin54.6%

Valuation Snapshot

latest market cap is EUR 8.74M.

About RENALYTIX PLC LS-0025

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.

Frequently asked questions

What is RENALYTIX PLC LS-0025's market cap?

RENALYTIX PLC LS-0025's market capitalization is EUR 8.74M.

What does RENALYTIX PLC LS-0025 do?

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States.